96 related articles for article (PubMed ID: 23083576)
21. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
22. A review of current evidence-based clinical applications for breast magnetic resonance imaging.
DeMartini W; Lehman C
Top Magn Reson Imaging; 2008 Jun; 19(3):143-50. PubMed ID: 18941394
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
24. What to do with B3 lesions at needle biopsy.
Linda A; Zuiani C; Londero V; Bazzocchi M
Eur J Radiol; 2012 Sep; 81 Suppl 1():S90-2. PubMed ID: 23083618
[No Abstract] [Full Text] [Related]
25. Screening for hereditary breast cancer.
Dent R; Warner E
Semin Oncol; 2007 Oct; 34(5):392-400. PubMed ID: 17920893
[TBL] [Abstract][Full Text] [Related]
26. [Value of breast MRI as supplement to mammography and sonography for high risk breast cancer patients].
Schlossbauer T; Hellerhoff K; Reiser M
Radiologe; 2008 Apr; 48(4):351-7. PubMed ID: 18347771
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of second-look ultrasound: is there a way to make it objective?
Fausto A; Casella D; Mantovani L; Giacalone G; Volterrani L
Eur J Radiol; 2012 Sep; 81 Suppl 1():S36-40. PubMed ID: 23083595
[No Abstract] [Full Text] [Related]
28. [Magnetic resonance versus traditional breast imaging in solid nodular diseases of the breast].
Ercolani P; Giuseppetti GM; Greco A; Manna P; Baldassarre S; Giovagnoni A; De Nigris E; Amici F
Radiol Med; 1994; 87(1-2):36-40. PubMed ID: 8128030
[TBL] [Abstract][Full Text] [Related]
29. Can breast MRI facilitate decision-making in equivocal mammography and ultrasonography findings?
Ozcan UA; Ocak F; Altun E
Eur J Radiol; 2012 Sep; 81 Suppl 1():S112-3. PubMed ID: 23083552
[No Abstract] [Full Text] [Related]
30. JOURNAL CLUB: Is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results.
Arazi-Kleinman T; Skair-Levy M; Slonimsky E; Maly B; Uziely B; Libson E; Sella T
AJR Am J Roentgenol; 2013 Oct; 201(4):919-27. PubMed ID: 24059385
[TBL] [Abstract][Full Text] [Related]
31. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS).
Leach MO; Eeles RA; Turnbull LW; Dixon AK; Brown J; Hoff RJ; Coulthard A; Dixon JM; Easton DF; Evans DG; Gilbert FJ; Hawnaur J; Hayes C; Kessar P; Lakhani S; Liney G; Moss SM; Padhani AP; Pointon LJ; Sydenham M; Walker LG; Warren RM; Haites NE; Morrison P; Cole T; Rayter Z; Donaldson A; Shere M; Rankin J; Goudie D; Steel CM; Davidson R; Chu C; Ellis I; Mackay J; Hodgson SV; Homfray T; Douglas F; Quarrell OW; Eccles DM; Gilbert FG; Crothers G; Walker CP; Jones A; Slack N; Britton P; Sheppard DG; Walsh J; Whitehouse G; Teh W; Rankin S; Boggis C; Potterton J; McLean L; Gordon PA; Rubin C;
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):107-14. PubMed ID: 12585664
[TBL] [Abstract][Full Text] [Related]
32. [Breast cancer screening for women with a strong familial risk].
Eisinger F
Bull Cancer; 2005 Oct; 92(10):874-84. PubMed ID: 16266871
[TBL] [Abstract][Full Text] [Related]
33. Clinical practice. Management of an inherited predisposition to breast cancer.
Robson M; Offit K
N Engl J Med; 2007 Jul; 357(2):154-62. PubMed ID: 17625127
[No Abstract] [Full Text] [Related]
34. Breast cancer screening with MRI--what are the data for patients at high risk?
Liberman L
N Engl J Med; 2004 Jul; 351(5):497-500. PubMed ID: 15282358
[No Abstract] [Full Text] [Related]
35. MRI in breast cancer.
Altundag K; Morandi P; Altundag O
N Engl J Med; 2004 Nov; 351(21):2235-6; author reply 2235-6. PubMed ID: 15548786
[No Abstract] [Full Text] [Related]
36. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).
Kuhl CK
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663
[TBL] [Abstract][Full Text] [Related]
37. Extramammary findings in T2-weighted MR breast images.
Verslegers I; Van Goethem M; Hufkens G; Biltjes I; Parizel PM
Eur J Radiol; 2012 Sep; 81 Suppl 1():S181-2. PubMed ID: 23083582
[No Abstract] [Full Text] [Related]
38. Familial tubular breast carcinoma.
Boets A; Van Steen A; Van Ongeval C; Drijkoningen R; Christiaens B
JBR-BTR; 2005; 88(3):114-5. PubMed ID: 16038219
[No Abstract] [Full Text] [Related]
39. Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.
Essink-Bot ML; Rijnsburger AJ; van Dooren S; de Koning HJ; Seynaeve C
Breast; 2006 Oct; 15(5):673-6. PubMed ID: 16556497
[TBL] [Abstract][Full Text] [Related]
40. Treating the genetic make-up of breast cancer: a new fashion?
Linn SC; Jonkers J
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1065-7. PubMed ID: 17725409
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
